Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

04. April 2019 08:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology Announces the Addition of Eugene Zhukovsky, Expert in Bispecific Biotherapeutics Development, to its Scientific Advisory Board

EMERYVILLE, Calif., April 04, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
03. April 2019 16:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology to Present at Needham Healthcare Conference

EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
02. April 2019 16:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology Presents Data at AACR Demonstrating MHC Class II Neoantigen Prediction with EDGE™ Significantly Outperforms Current Prediction Methods

EMERYVILLE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
28. März 2019 16:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights

EMERYVILLE, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
21. März 2019 16:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001

EMERYVILLE, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
11. März 2019 08:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth

EMERYVILLE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to...
05. März 2019 16:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology to Present at Two Upcoming Investor Conferences in March

EMERYVILLE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
27. Februar 2019 18:12 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology Announces Oral Presentation on MHC Class II Antigen Prediction at the AACR Annual Meeting in April 2019

--MHC Class II Antigen Prediction by Gritstone’s Proprietary Artificial Intelligence Platform EDGETM Shows Significant Improvement Over Standard Prediction Tools -- -- EDGE Enables...
20. Februar 2019 16:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology to Present at Leerink Partners Annual Global Healthcare Conference

EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...
06. Januar 2019 08:00 ET | Quelle: Gritstone Oncology, Inc

Gritstone Oncology Announces Updated Presentation Time at the 37th Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif., Jan. 06, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight...

Vorherige Seite